Prio Wealth Limited Partnership Novartis Ag Transaction History

Prio Wealth Limited Partnership

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 22, 2024	BUY	$92.27 - $101.54 $10,149 - $11,169	110 Added 4.6%	2,503 $252,000
Q3 2023 Oct 31, 2023	BUY	$94.73 - $105.13 $30,503 - $33,851	322 Added 15.55%	2,393 $243,000
Q2 2023 Aug 08, 2023	SELL	$92.52 - $104.91 $18,504 - $20,982	-200 Reduced 8.81%	2,071 $208,000
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $9,683 - $11,230	-121 Reduced 5.06%	2,271 $208,000
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $69,808 - $85,488	-924 Reduced 27.86%	2,392 $0
Q1 2022 Feb 21, 2023	SELL	$80.11 - $90.62 $7,770 - $8,790	-97 Reduced 4.06%	2,295 $201,000
Q4 2021 Feb 17, 2022	SELL	$79.7 - $88.13 $54,594 - $60,369	-685 Reduced 17.12%	3,316 $290,000
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $7,114 - $8,277	-87 Reduced 2.13%	4,001 $327,000
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $25,486 - $28,150	-299 Reduced 6.82%	4,088 $373,000
Q1 2021 May 06, 2021	BUY	$83.5 - $98.47 $28,974 - $34,169	347 Added 8.59%	4,387 $375,000
Q4 2020 Feb 04, 2021	BUY	$78.07 - $94.43 $73,307 - $88,669	939 Added 30.28%	4,040 $381,000
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $15,360 - $17,017	187 Added 6.42%	3,101 $270,000
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $249,263 - $274,673	2,914 New	2,914 $253,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Prio Wealth Limited Partnership with notifications on news.